siRNA, Anti-DBI, 2'-MOE-modified(CAT#: SIRGT08099WQ-2MOE)
The product SIRGT08099WQ-2MOE is a type of small interfering RNA (siRNA) that targets DBI gene and regulates the expression of gene. The siRNA interferes with the expression of DBI gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| Modification | 2'-O-methoxyethyl (2'-MOE) |
| Scale | 20/50/100/200 nmole |
| NCBI RefSeq | NM_001079862.2; NM_001079863.1; NM_001178017.1; NM_001178041.2; NM_001178042.2; NM_001178043.2; NM_001282633.1; NM_001282634.1; NM_001282635.1; NM_001282636.1; NM_001352432.1; NM_020548.7 |
| Alternative Names | ACBD1; ACBP; CCK-RP; EP |
| Related Diseases | Hepatic Coma, Zellweger Syndrome |
| Purification | HPLC |
